Search
Date and Time
Wednesday, March 21, 2018
6:00 PM – 8:30 PM

Location
Washington Marriott Georgetown Hotel
1221 22nd Street NW
Washington, DC 20037
Click Here for directions


Activity Co-Chairs
Chaitra Ujjani, MD (pictured top)
MedStar Georgetown University Hospital

Kieron Dunleavy, MD (pictured middle)
George Washington University Cancer Center

Mark Roschewski, MD (pictured bottom)
National Cancer Institute

Register online here

Chaitra Ujjani, MD Kieron Dunleavy, MD

Please note: Only representatives from supporting pharmaceutical companies are invited to register. If your company is interested in becoming a Lymphoma Rounds supporter please contact Piper Harmon, pharmon@lymphoma.org. Exhibit opportunities are also available, however, space is limited.


Program Agenda –

6:00 PM Registration and Dinner Buffet

6:45 PM Welcome Piper Harmon, Lymphoma Research Foundation

7:00 PM A Patient with CLL Mayur Narkhede, MD, MedStar Georgetown University Hospital

Moderator
Chaitra Ujjani, MD, MedStar Georgetown University Hospital

7:30 PM Two Cases of Untreated Follicular Lymphoma Andy Itsara, MD, National Cancer Institute

Moderator

Mark Roschewski, MD, National Cancer Institute

8:00 PMTBA

Kieron Dunleavy, MD, George Washington University Cancer Center

8:30 PM Adjourn



2017–18 Washington DC Lymphoma Rounds Series –

Wednesday, March 21, 2018

About the Program
The Lymphoma Research Foundation's Washington DC Lymphoma Rounds program provides a forum for healthcare professionals to meet on a regular basis and address issues specific to the diagnosis and treatment of their lymphoma patients. Participants will network, share best practices and learn the latest information on new therapies and advances in the management of lymphoma through interactive case studies presented by lymphoma experts in the Washington DC area.

At the conclusion of this educational activity, the participant should be better able to:

  • Summarize the latest developments in lymphoma diagnosis, treatment and management.
  • Apply best practices for treating lymphoma patients.
  • Inform patients about potential clinical trial opportunities.
  • Establish a network of health care professionals who work with lymphoma patients.

Additional Information
This program is free for healthcare professionals; however, pre-registration is required. Food and refreshments will be provided for all registered participants.

Sponsors






This activity is supported by educational grants from:

AbbVie, Celgene, Genentech, Juno Therapeutics, Kite Pharma, Pharmacyclics LLC and Janssen Biotech, Inc., Seattle Genetics, Spectrum Pharmaceuticals, Teva Pharmaceuticals Industries, LTD and TG Therapeutics


Joint Providership Statement

This activity has been planned and implemented in accordance with the Accreditation Requirements and Policies of the Accreditation Council for Continuing Medical Education through the joint providership of the University of Nebraska Medical Center, Center for Continuing Education and the Lymphoma Research Foundation.

Accreditation Statement

The University of Nebraska Medical Center, Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Statement

The University of Nebraska Medical Center, Center for Continuing Education designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit (s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.